drugset / Trial / NCT02158689
Comparison of Treatment Modalities in Poor Responders Undergoing IVF
RandomizedParallel-groupOpen-labelTreatment
Summary
The accurate identification and efficient management of poor responders remains one of the most enigmatic challenges in assisted reproductive technology (ART). The investigators study will compare the letrozole/antagonist protocol to the hMG/antagonist protocol in women who poor responders.
Timeline
- Start
- 2014-06
- Primary completion
- 2015-08
- Completion
- 2015-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Letrozole | Other / unclassified | 5 mg | — |
| Comparator | human chorionic gonadotropin | Protein / enzyme biologic | 150 iu | — |
| Comparator | human chorionic gonadotropin | Protein / enzyme biologic | 300 iu | — |
Indications
No indication recorded.